Davy Global Fund Management Ltd
- SEC CIK
- 0001620943
- Latest filing
- Jul 31, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by Davy Global Fund Management Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,604,317
- Value
- $9.56M
- % of portfolio
- 0.6%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,604,317 | $9.56M | 0.6% | +46,914+1.8% | Added | Holders |
| Q1 2026 | 2,557,403 | $7.85M | 0.6% | +153,285+6.4% | Added | Holders |
| Q4 2025 | 2,404,118 | $9.83M | 0.7% | +629,123+35.4% | Added | Holders |
| Q3 2025 | 1,774,995 | $8.66M | 0.6% | +863,910+94.8% | Added | Holders |
| Q2 2025 | 911,085 | $4.61M | 0.4% | +523,848+135.3% | Added | Holders |
| Q1 2025 | 387,237 | $2.05M | 0.2% | +186,767+93.2% | Added | Holders |
| Q4 2024 | 200,470 | $1.36M | 0.2% | +118,118+143.4% | Added | Holders |
| Q3 2024 | 82,352 | $542.7K | 0.1% | +42,101+104.6% | Added | Holders |
| Q2 2024 | 40,251 | $301.9K | <0.1% | +40,251 | New | Holders |